BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 337 filers reported holding BIONTECH SE in Q3 2021. The put-call ratio across all filers is 1.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,154 | -6.1% | 10,619 | -6.7% | 0.00% | -33.3% |
| Q2 2023 | $1,229 | -15.2% | 11,385 | -2.2% | 0.00% | 0.0% |
| Q1 2023 | $1,450 | +14.4% | 11,640 | +38.0% | 0.00% | 0.0% |
| Q4 2022 | $1,267 | -99.9% | 8,437 | -36.3% | 0.00% | -40.0% |
| Q3 2022 | $1,787,000 | +162.4% | 13,253 | +190.1% | 0.01% | +150.0% |
| Q2 2022 | $681,000 | -20.7% | 4,569 | -9.3% | 0.00% | 0.0% |
| Q1 2022 | $859,000 | -51.7% | 5,038 | -26.9% | 0.00% | -50.0% |
| Q4 2021 | $1,777,000 | -17.6% | 6,895 | -12.8% | 0.00% | -20.0% |
| Q3 2021 | $2,157,000 | +19.8% | 7,903 | -1.7% | 0.01% | 0.0% |
| Q2 2021 | $1,800,000 | +92.5% | 8,042 | -6.2% | 0.01% | +66.7% |
| Q1 2021 | $935,000 | +47.2% | 8,570 | +9.9% | 0.00% | +50.0% |
| Q4 2020 | $635,000 | +64.9% | 7,801 | +40.2% | 0.00% | +100.0% |
| Q3 2020 | $385,000 | – | 5,563 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 1,053,640 | $179,709,000 | 15.52% |
| Bill & Melinda Gates Foundation | 148,674 | $25,400,000 | 13.66% |
| Baader Bank Aktiengesellschaft | 224,800 | $38,342,000 | 3.07% |
| Quinn Opportunity Partners LLC | 402,239 | $68,606,000 | 2.96% |
| Pendal Group Ltd | 1,957,594 | $333,887,000 | 2.75% |
| Boston Common Asset Management, LLC | 280,181 | $47,788,000 | 2.06% |
| Tri Locum Partners LP | 30,923 | $5,274,000 | 2.06% |
| Renaissance Capital LLC | 25,267 | $4,310,000 | 1.83% |
| Robbins Farley | 13,220 | $2,255,000 | 1.70% |
| APEIRON CAPITAL Ltd | 21,300 | $3,633,000 | 1.61% |